Kezar Life Sciences, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
BOLT
Bolt Biotherapeutics, Inc. |
$0.62 | $29.02 M | -0.46 | 100 | $7.88 M |
CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
DSGN
Design Therapeutics, Inc. |
$6.31 | $217.51 M | -3.7 | 54 | $0 |
FHTX
Foghorn Therapeutics Inc. |
$4.66 | $332.53 M | -2.73 | 112 | $22.60 M |
GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
HOWL
Werewolf Therapeutics, Inc. |
$1.62 | $151.66 M | -3.17 | 46 | $1.89 M |
IKNA
Ikena Oncology, Inc. |
$1.66 | $84.45 M | -1.11 | 14 | $0 |
IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
KYMR
Kymera Therapeutics, Inc. |
$39.90 | $2.02 B | -13.13 | 188 | $47.07 M |
LRMR
Larimar Therapeutics, Inc. |
$3.96 | $611.84 M | -9.99 | 42 | $0 |
LYEL
Lyell Immunopharma, Inc. |
$0.68 | $619.50 M | -2.7 | 224 | $61,000 |
MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
NGM
NGM Biopharmaceuticals, Inc. |
$1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
NKTX
Nkarta, Inc. |
$2.46 | $465.09 M | -2.81 | 159 | $0 |
NRIX
Nurix Therapeutics, Inc. |
$19.22 | $930.10 M | -5.89 | 286 | $54.55 M |
RVMD
Revolution Medicines, Inc. |
$43.84 | $6.66 B | -10.51 | 534 | $0 |
SRZN
Surrozen, Inc. |
$14.23 | $35.47 M | -0.6 | 42 | $0 |
STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
STTK
Shattuck Labs, Inc. |
$1.27 | $333.81 M | -3.64 | 75 | $1.66 M |
THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
